TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.
Kvistborg P, Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, van Rooij N, Linnemann C, van Buuren MM, Urbanus JH, Beltman JB, Thor Straten P, Li YF, Robbins PF, Besser MJ, Schachter J, Kenter GG, Dudley ME, Rosenberg SA, Haanen JB, Hadrup SR, Schumacher TN.
Kvistborg P, et al. Among authors: thrue ca.
Oncoimmunology. 2012 Jul 1;1(4):409-418. doi: 10.4161/onci.18851.
Oncoimmunology. 2012.
PMID: 22754759
Free PMC article.